Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

ASP Isotopes (ASPI) Receivables - Other (2025)

ASP Isotopes has reported Receivables - Other over the past 1 years, most recently at $2.3 million for Q4 2025.

For Q4 2025, Receivables - Other changed N/A year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, changed N/A, while the annual FY2025 figure was $2.3 million, N/A changed from the prior year.
Receivables - Other for Q4 2025 was $2.3 million at ASP Isotopes, up from $2.0 million in the prior quarter.
Over five years, Receivables - Other peaked at $2.3 million in Q4 2025 and troughed at $2.0 million in Q3 2025.